期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM LetPub Score 7.7
51 ratings
Rate
Reputation 8.8 Influence 6.5 Speed 9.3 | ||||||||||||||||||||||||
期刊簡稱 | AM J PHYSIOL-ENDOC M | ||||||||||||||||||||||||
ISSN | 0193-1849 | ||||||||||||||||||||||||
E-ISSN | 1522-1555 | ||||||||||||||||||||||||
h-index | 182 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.40%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://ajpendo.physiology.org/ | ||||||||||||||||||||||||
在線稿件提交 | http://ajpendo.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | American Physiological Society | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1980 | ||||||||||||||||||||||||
每年文章數 | 109每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 11.17% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0193-1849%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM] 的評論 | 撰寫評論 |
作者: 欢_1119 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-11 10:50:41 評論於 It's been 6 days since submission and the manuscript is still under review. Is it being reviewed or is it in the hands of the editor?(0) 讚! | 欢_1119 |
作者: zhongzhong123 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-25 16:55:54 評論於 How's it going now? Have you been rushing behind?(0) 讚! | zhongzhong123 |
作者: zhongzhong123 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-25 16:55:07 評論於 I submitted on the 20th, and as soon as I submitted it, it showed Manuscript Under Review. Is this in external review? How long does it usually take to hear back?(0) 讚! | zhongzhong123 |
作者: 艺天三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-28 21:11:35 評論於 Received on 3.27~ Wishing everyone good luck~(0) 讚! | 艺天三岁啦 |
作者: 艺天三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-19 15:50:48 評論於 Brother hug(0) 讚! | 艺天三岁啦 |
作者: 魔都水荷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-16 13:16:49 評論於 It has been 55 days since I submitted on 11/20, and it still shows Manuscript Under Review. Is this reasonable, my friends?(0) 讚! | 魔都水荷 |
作者: 艺天三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-12 10:46:29 評論於 Submitted on 11.23, it has been 50 days, with the status still showing Manuscript Under Review. Is this normal, friends?(0) 讚! | 艺天三岁啦 |
作者: 空明嘉茂 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-29 21:57:12 評論於 How about now?(0) 讚! | 空明嘉茂 |
作者: 天际听南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-19 09:05:08 評論於 Research focus: Metabolism experience sharing: Submitted on October 19th, looking forward to good news(0) 讚! | 天际听南 |
作者: 秀颖大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-18 14:40:01 評論於 How did the first trial submission get accepted three months after 24 weeks?? Isn't that contradictory??(0) 讚! | 秀颖大叔 |
作者: 小青小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-18 16:45:14 評論於 Do I need to submit all the raw data and the results of the repeated three experiments?(0) 讚! | 小青小哥哥 |
作者: 小青小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-18 12:38:00 評論於 Do I need to submit all raw data and results of three repeated experiments?(0) 讚! | 小青小哥哥 |
作者: 小青小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-18 11:32:59 評論於 Do I need to submit all original data and results from three repeated experiments?(0) 讚! | 小青小哥哥 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:40:30 評論於 The corresponding author is the overall responsible person for the project, responsible for the funding, design, writing of articles and quality control of the project. They are responsible for communication with the journal during submission, peer review, and the entire publication process(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:13:43 評論於 The number of corresponding authors for SCI journal papers is not necessarily limited to one, and there is no fixed standard for how many there can be. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only allow one corresponding author, if a paper has multiple corresponding authors, the first corresponding author listed will automatically be selected. For SCI journals that allow two corresponding authors, two corresponding authors can be listed. The same applies to other requirements, meaning the number of corresponding authors listed should comply with the specific regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiment and writing of the paper, and is the one whose signature appears first in the list of authors. However, in collaborative research, it is common to have co-first authors. There is no specific rule for the number of co-first authors, and it is heavily influenced by factors such as the workload and length of the paper, as well as the regulations of the publishing journal and the recognition of the institutions involved. Generally, having 2-4 first authors for an SCI paper is the most common scenario(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 15:29:22 評論於 What is the corresponding author?(0) 讚! | 修然小公主 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:54:09 評論於 Can a journal have multiple corresponding authors/first authors?(0) 讚! | Darlene Pepys |
作者: 晶燕小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-23 11:43:12 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Research focus: Diabetes Experience sharing: AJP-Endo has a very good reputation in physiology, a well-established journal. Submitted on September 10th, review completed on October 18th, with a major revision opportunity given (20 questions from two reviewers). Revised on November 20th, accepted on November 23rd. The Editor-in-Chief is very friendly, with his own judgment and opinions(0) 讚! | 晶燕小公主 |
作者: 深渊卫杰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-10 11:22:15 評論於 I do not accept meta(0) 讚! | 深渊卫杰 |
作者: Edwiin Judson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-29 16:32:28 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Research focus: Weight loss metabolism Reviewer experience: Very nice editor, thumbs up(0) 讚! | Edwiin Judson |
作者: 姣丽三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-25 09:07:01 評論於 Submitted three articles to Conscience Magazine(0) 讚! | 姣丽三岁啦 |
作者: Karen Flower 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-03 13:35:26 評論於 Do you have a submission template?(0) 讚! | Karen Flower |
作者: 幽香童童 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-25 14:26:58 評論於 Is the first instance really going to take 24 weeks?(0) 讚! | 幽香童童 |
作者: 血天翠翠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-11 18:36:47 評論於 Do I need to provide recommended reviewers for this journal? How many should I provide? Should I include them in the cover letter or fill out a form directly?(0) 讚! | 血天翠翠 |
作者: 血天翠翠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-11 09:12:18 評論於 Do I need to provide recommended reviewers for this journal? How many should I provide? Should it be included in the cover letter or filled out directly on a form?(0) 讚! | 血天翠翠 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us